Common Stock, Shares Authorized of Ventyx Biosciences, Inc. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Ventyx Biosciences, Inc. quarterly Common Stock, Shares Authorized history and change rate from Q4 2020 to Q3 2025.
  • Ventyx Biosciences, Inc. Common Stock, Shares Authorized for the quarter ending 30 Sep 2025 was 900,000,000, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Change (%)

Ventyx Biosciences, Inc. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 900,000,000 0 0% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 900,000,000 0 0% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 900,000,000 0 0% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 900,000,000 0 0% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 900,000,000 0 0% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 900,000,000 0 0% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 900,000,000 0 0% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 900,000,000 0 0% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 900,000,000 0 0% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 900,000,000 0 0% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 900,000,000 0 0% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 900,000,000 0 0% 31 Dec 2022 10-K 27 Feb 2024 2023 FY
Q3 2022 900,000,000 +463,751,414 +106% 30 Sep 2022 10-Q 04 Nov 2022 2022 Q3
Q2 2022 900,000,000 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 900,000,000 0 0% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 900,000,000 +852,396,168 +1791% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 436,248,586 30 Sep 2021 10-Q 18 Nov 2021 2021 Q3
Q1 2021 900,000,000 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 47,603,832 31 Dec 2020 10-K 24 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.